News & Updates

Dr Sherif Mahmoud was invited to present at the 46th Annual General Meeting of the Canadian Apheresis Group (CAG) November 7–8 in Montréal. The talk, titled, "Drug Dosing During Apheresis Therapy: What Clinicians Need to Know" spawned a number of interesting conversations with other attendees on bridging pharmacology and apheresis practice to optimize patient outcomes. A massive thank you to the Canadian Apheresis Group for putting together an outstanding meeting and fosterin

Congratulations to our Neuro-CPK team, who presented their research at the Neurocritical Care Society (NCS) Annual Meeting in Seattle and the Canadian Society of Healthcare-Systems Pharmacy–Alberta Branch Symposium (CABS) in Calgary in October. These events were a great chance for the team to connect with colleagues & share their ongoing work and they came home with many new ideas and avenues for future research. We are proud of all of them for their outstanding performances.

Congratulations to members of the Neuro-CPK team, whose work on 'super kidneys' was featured in the Faculty of Pharmacy + Pharmaceutical Sciences' annual magazine

Dr. Sherif Mahmoud Congratulations to Dr. Sherif Mahmoud for being selected as the recipient of the 2026 CSHP-AB (Canadian Society of Healthcare-Systems Pharmacy–Alberta Branch) Practitioner Award! This award recognizes significant contributions to hospital pharmacy practice. From the award letter: It is this kind of hard work and dedication to pharmacy practice that enables our profession to move forward. CSHP and the profession of pharmacy are truly fortunate to count indiv

Dr. Mahmoud with his graduate students and staff at the NMHI Research Day Congratulations to our Neuro-CPK graduate students, who presented their research at the annual NMHI Research Day at the University of Alberta, Edmonton. This event was a great chance for the students to share their ongoing work, exchange ideas, and explore future directions in neuroscience and mental health research. Particular congratulations to our PhD student, Maged Kharouba, for winning an award for

Congratulations to Maged Kharouba, Asma Aboelezz, Adham Elshamy, Dr. Sherif Mahmoud & coauthors for the publication of their recent paper in Separation Science Plus. Title: Development and Validation of an HPLC-UV Method for the Quantification of Cefepime in Human Plasma for Routine Clinical Monitoring Authors: Maged Kharouba, Asma Aboelezz, Adham Elshamy, Aaron M. Cook, Melissa L. Thompson Bastin, Sherif Hanafy Mahmoud Abstract: Cefepime, a broad-spectrum fourth-generation c

Congratulations to Asma Aboelezz & Dr. Sherif Mahmoud for the publication of their recent paper in Medicines. Title: The Role of Metabolites in Acyclovir-Induced Neurotoxicity and Nephrotoxicity Authors: Asma Aboelezz, Sherif Hanafy Mahmoud Abstract: Acyclovir is an antiviral drug effective against infections caused by herpes simplex and varicella zoster viruses. It is given intravenously to treat serious infections such as herpes encephalitis. High acyclovir concentrations c

Congratulations to Dr. Sherif Mahmoud & Asma Aboelezz for the publication of their recent paper in Journal of Advanced Pharmaceutical Sciences. Title: Implementation of pharmacogenomics within community pharmacies in Alberta, Canada: An observational study Authors: Dalia Amr Hamdy, Sherif Hanafy Mahmoud, Dareen Elsayed, Meagan Shields, Asma Aboelezz Abstract: Pharmacogenomics (PGx) use in Canadian community pharmacy is a new practice with limited application. This study sough

Congratulations to Maged Kharouba, Dr. Sherif Mahmoud & coauthors for the publication of their recent paper in Neurocritical Care. Title: Levetiracetam Dosing Optimization in Neurocritical Care Population: Neuro‑ARC Study Authors: Maged Kharouba, Aaron M. Cook, Melissa L. Thompson Bastin, Demetrios J. Kutsogiannis, Sherif Hanafy Mahmoud Abstract: Background: Levetiracetam, a first-line antiseizure medication, is primarily eliminated through the kidneys, with approximately 66%

Congratulations to Dr. Sherif Mahmoud, Maged Kharouba, Asma Aboelezz, Adham Elshamy & Ellen Gunn for the publication of their recent paper in Frontiers in Neurology. Title: Pharmacotherapy variability and precision medicine in neurocritical care Authors: Sherif Hanafy Mahmoud, Maged Kharouba, Asma Aboelezz, Adham Elshamy, Ellen Gunn Abstract: Pharmacotherapy variability is defined as the variability in drug response among and within individuals that is attributed to the inter

Congratulations to Dr. Sherif Mahmoud & coauthors for the publication of their recent paper in Future Journal of Pharmaceutical Sciences. Title: Extended stability of bivalirudin in intravenous solutions Authors: Sherif Hanafy Mahmoud, Forugh Sanaee, Jenna Smith, Lindsay Ryerson, Mary Bauman, Yvonne Rees, Elona Turley, Rashid Alobaidi, Marcel Romanick, Afsaneh Lavasanifar Abstract: Background: Bivalirudin is the preferred anticoagulant for pediatric ventricular assist device

Congratulations to Asma Aboelezz, Maged Kharouba & Dr. Sherif Mahmoud for the publication of their recent paper in Journal of Clinical Neuroscience. Title: Acyclovir dosing strategies in herpes encephalitis: A retrospective charts review Authors: Asma Aboelezz, Maged Kharouba, Sherif Hanafy Mahmoud Abstract: Background: Herpes encephalitis is a life-threatening condition that causes severe inflammation of the brain, often leading to permanent neurological damage or death if n

Congratulations to Dr. Sherif Mahmoud & coauthors for the publication of their recent paper in Neurocritical Care. Title: The Evolution of Neurocritical Care Pharmacy: Historical Perspectives and Future Horizons Authors: Denise H. Rhoney, Aaron M. Cook, Karen Berger, Sherif Hanafy Mahmoud, Gretchen M. Brophy, Salia Farrokh, Theresa Human, John Lewin, Jeffrey J. Mucksavage, Kiranpal S. Sangha, Eljim P. Tesoro Abstract: This article reviews the history and evolution of the neur

Congratulations to Asma Aboelezz, Maged Kharouba, Dr. Sherif Mahmoud & coauthors for the publication of their recent paper in Molecules. Title: The Development and Validation of a Simple HPLC-UV Method for the Determination of Vancomycin Concentration in Human Plasma and Application in Critically Ill Patients Authors: Asma Aboelezz, Novel Solomon Tesfamariam, Maged Kharouba, Tamara Gligoric, Sherif Hanafy Mahmoud Abstract: Vancomycin is an antimicrobial agent that exhibits hi

Congratulations to Maged Kharouba, Asma Aboelezz, Dr. Sherif Mahmoud & coauthors for the publication of their recent paper in The Journal of Clinical Pharmacology. Title: The Impact of Augmented Renal Clearance on the Pharmacokinetics of Levetiracetam in Critically Ill Patients: A Literature Review Authors: Maged Kharouba, Asma Aboelezz, Janice Y. Kung, Sherif Hanafy Mahmoud Abstract: Levetiracetam is an antiseizure medication (ASM) that has several advantages over other ASMs

Congratulations to Dr. Sherif Mahmoud & coauthors for the publication of their recent paper in Neurocritical Care. Title: Caring for Coma after Severe Brain Injury: Clinical Practices and Challenges to Improve Outcomes: An Initiative by the Curing Coma Campaign Authors: Brooke Murtaugh, DaiWai M. Olson, Neeraj Badjatia, Ariane Lewis, Venkatesh Aiyagari, Kartavya Sharma, Claire J. Creutzfeldt, Guido J. Falcone, Amy Shapiro‑Rosenbaum, Elizabeth K. Zink, Jose I. Suarez, Gisele S

This award recognizes a pharmacist who demonstrates leadership and exemplifies the evolution of the pharmacy profession toward an expanded role in health care. From the Canadian Pharmacists Association: Dr. Sherif Hanafy Mahmoud stands as a beacon of excellence in the field of pharmacy, with a career spanning over 2 decades characterized by remarkable achievements and contributions. Dr. Mahmoud completed a pharmacy degree and master’s in clinical pharmacy from Ain-Shams Unive

Congratulations to Asma Aboelezz, Maged Kharouba & Dr. Sherif Mahmoud for the publication of their recent paper in Future Journal of Pharmaceutical Sciences. Title: A simple method for the determination of acyclovir concentrations in human plasma using high-performance liquid chromatography Authors: Asma Aboelezz, Maged Kharouba, Sherif Hanafy Mahmoud Abstract: Background: Acyclovir is an anti-viral medication given to treat herpes simplex and herpes zoster infection. In some

Congratulations to Asma Aboelezz & Dr. Sherif Mahmoud for the publication of their recent paper in the Journal of the American Pharmacists Association. Title: Acyclovir dosing in herpes encephalitis: A scoping review Authors: Asma Aboelezz, Sherif Hanafy Mahmoud Abstract: Background: Herpes encephalitis, a rare yet potentially fatal viral infection, is treated exclusively with acyclovir, the sole antiviral medication used for this condition. Acyclovir recommended dose is 10 m

Congratulations to Dr. Sherif Mahmoud, Fatma Hefny, Fadumo Isse & coauthors for the publication of their recent paper in Frontiers in Neurology. Title: Nimodipine systemic exposure and outcomes following aneurysmal subarachnoid hemorrhage: a pilot prospective observational study (ASH-1 study) Authors: Sherif Hanafy Mahmoud, Fatma Hefny, Fadumo Ahmed Isse, Shahmeer Farooq, Spencer Ling, Cian O'Kelly, Demetrios James Kutsogiannis Abstract: Background: Nimodipine improves outcom